Editorial: Incidence and predictors of major gastrointestinal bleeding in patients on aspirin, low‐dose rivaroxaban or the combination: Secondary analysis of the COMPASS randomised controlled trial
Sehgal K, Shung D. Editorial: Incidence and predictors of major gastrointestinal bleeding in patients on aspirin, low‐dose rivaroxaban or the combination: Secondary analysis of the COMPASS randomised controlled trial. Alimentary Pharmacology & Therapeutics 2024, 60: 961-962. PMID: 39219413, DOI: 10.1111/apt.18195.Commentaries, Editorials and Letters